52* Essential Considerations in the Provision of near patient Testing Facilities
Ann Clin Biochem 1988; 25: 220-225
53* Identification and Treatment of Risk Factors for Coronary Heart Disease in General Practice: A Possible Screening Model
Jones A, Davies DH, Dove JR, et al (GPs at Swansea)
Br Med J 1988; 296: 1711-1714
55* Assessment of a Screening Method for Heart Disease.
Fam Pract 1988; 5: 297-301
56 Quality of Plasma Cholesterol Measurements in Primary Care
Broughton PMG, Bullock DG, Cramb R
Br Med J 1989; 298: 297-298
57 Blood Cholesterol: Is Population Screening Warranted in the United Kingdom?
Smith WCS, Kenicer MB, Davis AM, et al
Lancet 1989; 1: 372-373
58 Population Screening for Serum Cholesterol
Richter CD, Bailey AR
Lancet 1989; 1: 547-548
59 Title Uncertain - concerning reduction in risk on stopping smoking
New Eng J Med ?Jan 1990
60 Alcoholism: a controlled trial of 'treatment' and 'advice'
Edwards G et alia
J Stud Alcohol 1977; 38:1004-31
Simple advice with little follow-up achieves as much as intensive conventional treatment.
61 The hidden alcoholic in general practice
London: Elke Science 1974; Ch 3
Screening using a list of at risk indicators.
62 Patients' response to a self administered questionnaire.
Wallace P, Haines A
BMJ 1985; 290: 1949-53
10% of people expressed concern about drinking levels
63* Social Diseases
Practitioner 1990; 234; 164-5
64* Primary Prevention
Practitioner 1990; 234: 168 -70
65 Can Health Screening Damage Your Health?
JRCGP 1989, 39, 193-195
66 Mortality Rates After 10.5 years for Participants in the Multiple Risk Factor Intervention Trial (MRFIT).
The MRFIT Research Group
67 Consensus Conference - Lowering Blood Cholesterol to Prevent Heart Disease.
68 Rose G, Tunstall-Pedoe H, Heller R.
The United Kingdom Heart Disease Prevention Project. Incidence and Mortality Rates.
69 The Prevalence of Premature Coronary Heart Disease
British Cardiac Society Working Group on Coronary Heart Disease Prevention.
Br Heart J 1987;57:188-9
70 Serum Cholesterol, Blood pressure and Mortality: Implications from a Cohort of 361,662 Men
Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D
71 Increased Absenteeism from Work after detection and labelling of Hypertensive Patients.
Haynes R, Sackett D, Taylor D, et al
New Eng J Med 1978;299:741-744
72 A Controlled Trial of Multiphasic Screening in Middle Age - Results of the South East London Screening Study.
The South East London Study Group
Int J Epidemiol 1977;6:357-363
73 Manual of General Health Questionaires
Windsor NFER-Nelson 1978
74 Some Principles of Early Diagnosis and Detection.
Wilson JMG Teeling-Smith G (ed) Surveillance and Early Diagnosis in General Practice. 1965
Office of Health Economics Press London pp 5-10
75 Screening in General Practice.
Churchill Livingstone, Edinburgh 1975
76 Principles and Practice of Screening for Disease.
Wilson JMG and Junger G
Geneva WHO 1968
77 Diet and Cardiovascular Disease
Committee on Medical Aspects of Food Policy
DHSS Report on Health & Social Subjects No 28
HMSO London 1984
78 Proposals for Nutritional Guidelines for Health Education in Britain
National Advisory Committee on Nutrition Education
HEC London 1983
79 Risk Assessment: its Role in the Prevention of coronary heart disease
Recommendations of the scientific and medical advisory committee
The Coronary Prevention Group
Br Med Jour 1987:295;1246
80 Charles Chittenden et alia
Journ Amer Acad Actuaries 1990 ?May
81 Dr Brian Shaw, Glasgow quoted in Pulse May 90
82* Craig Lefebvre R, Gubata P, Ronan A, Carleton RA.
Variation in the Reflotron method of cholesterol measurement.
Amer J Cardiol 1990; 65: 916-7.
83* Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the laboratory standardization panel of the national cholesterol education program.
Clin Chem 1988; 34: 193-201.
84* Cholesterol Screening: Consensus development statement.
84a Norwich Health Authority. Undated (received 22/6/90)
85* Risk Assessment in the Prevention of Coronary Heart Disease
The Coronary Prevention Group
A Policy Statement 14/2/90
86 Bonithon-Kopp C, Scarabin P-Y, Darne B et alia.
Menopause related changes in lipoproteins and some other cardiovascular risk factors.
Int J Epidemiol 1990; 19: 42-47
87 Penn R, Worthington DJ.
Is serum gamma glutamyl transferase a misleading test?
BMJ 1983; 280: 531-5
88* Marteau TM.
Screening in practice: reducing the psychological costs.
BMJ 1990; 301: 26-28
89 Passive Smoking
BMJ 1989; 299: 423-427
90 Morris JN, Clayton DG, Everitt MG
Exercise at liesure time: Coronary attack and death rates
Br Heart J 1990; 63: 325-333
91 Author unknown
Obesity and coronary heart disease
N Engl J Med 1990; 322: 882-889
92 Author unknown
Screening for Alzheimers disease
Lancet 1990; 335: 747-750
93* Muldoon MF, Manuck SB, Matthews KA
Lowering Cholesterol Concentration and mortality: a quantitative review of primary prevention trials.
Brit Med J 1990; 301: 309-314
94 Sytkowski PA, Kannel WB, D'Agostino RB
Changes in risk factors and the decline in mortality from cardiovascular disease.
N Engl J Med 1990; 322(23): 1635-1641
95 Authors ??
Self Motivation to Stop Smoking
J Amer Med Assoc 1990; 263: 2760-2765
96* Naughton MJ, Luepker RV, Strickland D.
The Accuracy of Portable Cholesterol Analysers in public screening programmes.
J Am Med Assoc 1990; 263: 1213-1217
97 Benfante R, Reed D.
Is Elevated Serum Cholesterol Level a risk Factor for Coronary Heart Disease in the Elderly?
J Am Med Assoc 1990; 263: 393-396
98* Bonna K, Arnesen E, Thelle DS, Forde OH.
Coffee and Cholesterol: Is it all im the Brewing? The Tromso Study.
BMJ 1988; 297: 1103-1104
99 Leitch D.
BMJ 1989; 298: 1611 page may be incorrect
100 Francis J, Roche M, Mat D, Jones L, Fullard E.
Would primary health care workers give appropriate dietary advice after cholesterol screening?
BMJ 1989; 298: 1620
|Top of Page||Contents||Drop us a line or two||Index||Take your Takeheart Health Check now|